James Investment Research’s Federated Hermes FHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$494K Hold
8,952
0.05% 270
2026
Q1
$508K Buy
8,952
+12
+0.1% +$657 0.06% 252
2025
Q4
$466K Hold
8,940
0.05% 259
2025
Q3
$464K Buy
8,940
+1,044
+13% +$52.9K 0.05% 254
2025
Q2
$350K Hold
7,896
0.04% 257
2025
Q1
$322K Hold
7,896
0.04% 251
2024
Q4
$325K Hold
7,896
0.04% 260
2024
Q3
$290K Buy
7,896
+700
+10% +$24K 0.03% 276
2024
Q2
$237K Sell
7,196
-2
-0% -$67 0.03% 287
2024
Q1
$260K Hold
7,198
0.03% 274
2023
Q4
$244K Hold
7,198
0.03% 269
2023
Q3
$244K Buy
+7,198
New +$248K 0.03% 248
2019
Q1
Sell
-42,900
Closed -$1.14M 848
2018
Q4
$1.14M Buy
+42,900
New +$1.07M 0.07% 258
2018
Q2
Sell
-67,235
Closed -$2.25M 821
2018
Q1
$2.25M Buy
67,235
+3,030
+5% +$103K 0.08% 242
2017
Q4
$2.32M Buy
64,205
+3,305
+5% +$107K 0.08% 227
2017
Q3
$1.81M Buy
+60,900
New +$1.71M 0.06% 309

Other funds holding FHI

James Investment Research's FHI Position: Q2 2026 in Review

James Investment Research held its Federated Hermes (FHI) position steady in Q2 2026 at 8,952 shares worth $494K. The position accounts for 0.05% of the portfolio, ranked #270.

James Investment Research first reported a position in FHI in Q3 2017 and has held it in 16 quarters since. The position peaked at $2.32M in Q4 2017. 390 funds tracked by Wall St. Rank hold FHI as of Q2 2026.

  • James Investment Research held 8,952 shares of Federated Hermes worth $494K as of Q2 2026.
  • James Investment Research left its Federated Hermes share count unchanged in Q2 2026.
  • Federated Hermes made up 0.05% of James Investment Research's portfolio in Q2 2026, its #270 holding.
  • James Investment Research first reported a position in Federated Hermes in Q3 2017 and has held it in 16 quarters since.
  • James Investment Research's Federated Hermes position peaked at $2.32M in Q4 2017.
  • 390 funds tracked by Wall St. Rank held Federated Hermes as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.